Koastal-1 | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

58,515 results for “Koastal-1”

Neumora's Navacaprant Fails Phase 3 Trial for Major Depressive Disorder

Neumora's Depression Drug Navacaprant Fails Phase III Trial, Shares Plummet

Neumora Halts Navacaprant Development After Three Phase III Failures in Major Depressive Disorder, Cuts 35% of Workforce

Neumora's Depression Drug Navacaprant Fails Phase III Trial, Triggering Stock Plunge and Legal Investigation

Neumora Therapeutics Awaits Key Data Readouts for Navacaprant in Major Depressive Disorder

Neumora Therapeutics Outlines 2026 Pipeline Strategy with Multiple Clinical Readouts Expected

Gilead's Lenacapavir Shows Promise in HIV Prevention, While GLP-1s Studied for Type 1 Diabetes

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Gene Therapy Vector

GLP-1 Drug Use Surges Among Type 1 Diabetes Patients Despite Safety Concerns

GLP-1 Receptor Agonists Prescriptions Rise for Off-Label Use in Type 1 Diabetes

Page 1 of 1514